Epizyme Inc (NASDAQ:EPZM) has received a consensus recommendation of “Hold” from the eleven ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating on the company. The average 1-year target […]
